CENTENE CORP (CNC)
Health Care / Managed Health Care
S&P 500$54.94
Below average on several measures. Research carefully.
Weak
Score based on 4 of 5 models — moderate confidence
Is CENTENE CORP a Good Investment in 2026?
CENTENE CORP (CNC) scores 4.5 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Lynch model rates CENTENE CORP as Attractive. However, the Greenblatt Magic Formula model rates it Caution — Bottom half (rank 98%). CENTENE CORP currently trades below its estimated fair value of $89, suggesting potential upside. CENTENE CORP ranks #709 out of 1126 stocks in the Health Care sector.
This summary is algorithmically generated and is not financial advice.
Key Metrics
Estimated Fair Value
Fair value above market price — fundamentals support a higher valuation.
Model-based estimate, not a price target.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Neutral
4/9
Buffett
Caution
Business quality & competitive moat
Graham
Caution
Price vs intrinsic value
Lynch
Attractive
Growth rate vs price (PEG)
Greenblatt
Caution
Bottom half (rank 98%)
Frequently Asked Questions
Is CENTENE CORP (CNC) a good investment?
What is CENTENE CORP's Piotroski F-Score?
Is CNC overvalued or undervalued?
How does CNC compare to other Health Care stocks?
What do investment models say about CNC?
Similar Stocks
Compare CNC with
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer